What is he best known for?
The fields of study he is best known for:
- Cancer
- Immune system
- Gene
His main research concerns Immunology, Immune system, T cell, Tumor microenvironment and Cancer research.
Immunology and Oncology are commonly linked in his work.
His Immune system research integrates issues from Autophagy, Cancer and Effector.
Thomas F. Gajewski has researched T cell in several fields, including Neoplasm, Dendritic cell, CD8, Cytotoxic T cell and Programmed cell death.
He combines subjects such as Cancer cell, SCNA, Cancer immunotherapy, Priming and FOXP3 with his study of Tumor microenvironment.
He usually deals with Immunotherapy and limits it to topics linked to Melanoma and Internal medicine, Enterococcus faecium and PTEN.
His most cited work include:
- Innate and adaptive immune cells in the tumor microenvironment (1787 citations)
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy (1425 citations)
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity (1236 citations)
What are the main themes of his work throughout his whole career to date?
Thomas F. Gajewski mostly deals with Immunology, Cancer research, T cell, Immune system and Immunotherapy.
His research on Immunology frequently links to adjacent areas such as Melanoma.
His Melanoma research includes elements of Internal medicine, Oncology and Pathology.
His research in Cancer research intersects with topics in Signal transduction and In vivo.
His research in T cell focuses on subjects like Cell biology, which are connected to T-cell receptor.
His Immunotherapy study integrates concerns from other disciplines, such as Clinical trial and Cytokine.
He most often published in these fields:
- Immunology (43.31%)
- Cancer research (29.30%)
- T cell (29.30%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunotherapy (25.05%)
- Immune system (28.24%)
- Cancer research (29.30%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Immunotherapy, Immune system, Cancer research, Immunology and Tumor microenvironment.
His Immunotherapy study combines topics in areas such as Melanoma and Oncology.
The various areas that Thomas F. Gajewski examines in his Immune system study include Disease and Combination therapy.
Cytotoxic T cell is closely connected to CD8 in his research, which is encompassed under the umbrella topic of Cancer research.
His Endogeny research extends to Immunology, which is thematically connected.
Tumor microenvironment is closely attributed to Antigen in his work.
Between 2015 and 2021, his most popular works were:
- The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients (857 citations)
- Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy (658 citations)
- Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (611 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Immune system
Thomas F. Gajewski mainly focuses on Immunotherapy, Immunology, Tumor microenvironment, Cancer research and Immune system.
His work carried out in the field of Immunotherapy brings together such families of science as T cell, Combined Modality Therapy and Oncolytic virus.
His work on Melanoma expands to the thematically related Immunology.
His Tumor microenvironment research is multidisciplinary, relying on both Targeted therapy, Chimeric antigen receptor, Antigen and Adoptive cell transfer.
His Cancer research study incorporates themes from TACSTD2, Catenin, Combination therapy and Ovarian cancer.
His CD8, Immunity, Acquired immune system and Immune privilege study in the realm of Immune system interacts with subjects such as DSC3.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
